Cell Therapeutics CTIC Group

Comment

Comment by Stocks To Buy on December 6, 2011 at 2:42pm

CTIC news out - the stock is moving back to $1.40 area - http://www.stockstobuy.org/forum/topics/cell-therapeutics-ctic-stoc...

Comment by Stocks To Buy on November 13, 2011 at 7:15am

Cell Therapeutics ( CTIC ) recently tried to break out of a downtrend but failed in the $1.30's. I think CTIC needs to hold $0.95-$1 for the rest of 2011 and into 2012 or the stock will go down. CTIC will break out and start going up when it breaks $1.30

Comment by Stocks To Buy on April 20, 2011 at 8:58am

Cell Therapeutics, Inc. (CTIC) back in the $0.40's and looking strong in pre market - watch CTIC

Comment by Stocks To Buy on March 23, 2011 at 12:11pm

Cell Therapeutics, Inc. (CTIC) is digesting the recent move over the past week. CTIC will have resistance located at $0.48 followed by $0.55. CTIC will have support located at $0.40, a break below $0.40 at this point would be bearish. The stock can go either way at this point.

Comment by Stocks To Buy on March 21, 2011 at 7:53am

Cell Therapeutics (CTIC) Initiates Pixantrone PIX-R Pivotal Trial for Treatment of Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

Comment by Stocks To Buy on March 17, 2011 at 7:23am

Cell Therapeutics Inc. (Nasdaq:CTIC) is trading at $0.37 in pre market today, we need to see what happens in regular trading but it is looking good so far.  CTIC will have major resistance between $0.40-$0.43

Comment by Stocks To Buy on March 16, 2011 at 10:21am

Cell Therapeutics Inc. (Nasdaq:CTIC) opened at $0.35, ran to $0.355, fell to $0.32 which is now support.

Comment by Stocks To Buy on March 16, 2011 at 8:19am

Cell Therapeutics Inc. (Nasdaq:CTIC) up to $0.35 in pre market

Comment by Stocks To Buy on March 14, 2011 at 9:18am

CTIC will have resistance at $0.33 but then nothing major until about $0.38-$0.39.  If it can get back above $0.40 it has a chance to run further.  $0.43-$0.44 is also major resistance

Comment by Stocks To Buy on March 14, 2011 at 8:44am

Cell Therapeutics (CTIC) Acquires Exclusive Marketing and Co-Development Rights in the Americas to Chroma Therapeutics' Tosedostat, a First in Class Tumor Selective Oral Therapy for Treatment of Blood Related and Other Cancers - http://finance.yahoo.com/news/Cell-Therapeutics-Acquires-prnews-407...

• ‹ Previous
• 1
• 2
• 3
• 4
• Next ›
• Page